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Abbreviations 
ATP   adenosine triphosphate 
ANOVA  analysis of variance 
BSA   bovine serum albumin 
CLP   cecal ligation and puncture 
CoA   coenzyme A 
CPT I    carnitine palmitoyltransferase I 
CPT II   carnitine palmitoyltransferase II 
CSS   clinical severity score 
DTNB   5,5'-dithiobis-2-nitrobenzoic 
EDTA   ethylenediaminetetraacetic acid 
FADH2  flavin adenine dinucleotide 
FAO   fatty acid oxidation 
GO   glucose oxidation 
GO/FAO  ratio of glucose oxidation to fatty acid oxidation 
GLUT4  glucose transporter 4 
HCR   high capacity runners 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
IR   insulin resistance 
IRS-1   insulin receptor substrate 1 
KH   Krebs-Henseleit 
LCR   low capacity runners 
LPS   lipopolysaccharide 
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LVEF   left ventricular ejection fraction 
NADH  nicotinamide adenine dinucleotide 
PCI   peritoneal contamination and infection 
PDH   pyruvate dehydrogenase 
PI3K   phosphatidylinositol 3-kinase 
SCM   septic cardiomyopathy 
TCA   tricarboxylic acid cycle 
TNF-α   tumor necrosis factor alpha 
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Summary 
Background: Sepsis, defined as life-threatening organ dysfunction caused by a dysregulated 
host response to infection, represents a global health issue due to high prevalence and 
mortality. Manifestation of septic cardiomyopathy (SCM), one of many complications in 
sepsis, is associated to a worse outcome. The molecular features of SCM and septic effects on 
cardiac metabolism are not sufficiently characterized. Genetic predisposition for exercise 
capacity may be one factor influencing the course of sepsis. Sepsis-survival experiments with 
high capacity runners (HCR) and low capacity runners (LCR), a rat model for intrinsic 
exercise capacity, linked high exercise capacity to an advantage in survival 24 h after sepsis 
induction. The reasons for this advantage are unknown. We intend to identify potential sepsis-
related alterations of cardiac metabolism and function that may be responsible for the 
mentioned findings and aim to uncover new metabolic mechanisms involved in the 
development of sepsis-associated cardiac dysfunction.  
 
Methods: Sepsis was induced by intraperitoneal injection of a pooled human stool sample in 
male HCR and LCR rats at the age of 15 weeks. Isolated working heart perfusions were 
performed without sepsis induction as well as 24-36 h, 4-5 d and 4-5 w after sepsis induction 
with modified Krebs-Henseleit buffer containing glucose (5 mM) and sodium oleate (0.4 mM) 
bound to 1% bovine serum albumin (BSA). [U-14C]-glucose and [9,10-3H]-oleate were added 
to the perfusion medium to assess cardiac glucose and fatty acid oxidation. After 30 min of 
baseline perfusion, insulin was administered to evaluate cardiac insulin sensitivity. Cardiac 
function and performance were monitored continuously throughout the experiment. 
Morphological parameters of the rats including body and heart weight were recorded. 
Enzymatic activities of carnitine palmitoyltransferase I and II were determined using a 
spectrophotometric method.  
 
Results: LCR rats weighed significantly more than HCR rats. A similar tendency was 
observed for heart weights. Cardiac performance assessed ex vivo during isolated working 
heart perfusions was neither compromised in acute sepsis nor in sepsis-survivors and did not 
depend on intrinsic exercise capacity. LCR hearts tended to oxidize more glucose and less 
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oleate than HCR hearts. Acute sepsis and survival of sepsis were not associated to relevant 
alterations of basal cardiac substrate oxidation. Insulin sensitivity was preserved in all groups 
at all investigated time points, indicated by a robust increase of glucose oxidation and 
decrease of fatty acid oxidation after insulin stimulation. Carnitine palmitoyltransferase I and 
II activities were not changed during sepsis and were not influenced by intrinsic exercise 
capacity.  
 
Conclusion: Sepsis did not induce substantial disturbances of cardiac metabolism or function. 
Genetic predisposition for intrinsic exercise capacity did not affect cardiac substrate oxidation 
during acute sepsis or in sepsis-survivors. We conclude that the detrimental effects of sepsis 
cannot be attributed to metabolic or mechanical dysfunction of the heart in our model. The 
mechanisms mediating the advantage in 24 h survival associated to high intrinsic exercise 
capacity remain elusive. 
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Zusammenfassung 
Hintergrund: Die Sepsis, definiert als eine lebensbedrohliche Organdysfunktion verursacht 
durch eine überschießende Immunantwort des Organismus auf eine Infektion, stellt ein 
globales Gesundheitsproblem mit hoher Prävalenz und Mortalität dar. Das Auftreten einer 
septischen Kardiomyopathie (SCM), einer der vielen Komplikationen im Rahmen der Sepsis, 
ist mit einem ungünstigeren Krankheitsverlauf assoziiert. Die molekularen Eigenschaften der 
SCM und Effekte der Sepsis auf den Herzstoffwechsel generell sind nicht hinreichend 
charakterisiert. Ein Faktor, der den Verlauf einer Sepsis beeinflussen könnte, ist die 
genetische Prädisposition für intrinsische Leistungskapazität. In Versuchen mit septischen 
Ratten mit hoher (HCR) und niedriger (LCR) intrinsischer Leistungskapazität zeigte sich, dass 
Tiere mit hoher Leistungskapazität Vorteile im Überleben 24 h nach Sepsisinduktion 
aufwiesen. Die Ursachen dieses Überlebensvorteils blieben unklar. Die vorliegende Arbeit 
zielt darauf ab, potentielle Veränderungen von Herzstoffwechsel und -funktion im Rahmen 
einer Sepsis zu beschreiben, die möglicherweise mitverantwortlich für die festgestellten 
Unterschiede im Überleben sind, und neue metabolische Mechanismen zu entdecken, welche 
zur Entwicklung einer Sepsis-assoziierten kardialen Dysfunktion beitragen.      
 
Methoden: In männlichen HCR und LCR Ratten im Alter von 15 Wochen wurde eine Sepsis 
durch intraperitoneale Injektion einer gepoolten humanen Stuhlsuspension induziert. Nach  
24-36 h, 4-5 d und 4-5 w wurden die Ratten euthanasiert, um isoliert arbeitende 
Herzperfusionen mit modifiziertem Krebs-Henseleit-Buffer, angereichert mit Glukose (5 mM) 
und Oleat (0.4 mM) gebunden an 1% BSA, durchzuführen. [U-14C] -Glukose und  
[9,10-3H] -Oleat wurden dem Perfusionsmedium zugegeben, um den kardialen Glukose- und 
Fettsäurestoffwechsel quantitativ einzuschätzen. Nach einer Perfusionszeit von 30 min zur 
Messung der basalen Substratoxidation wurde Insulin zur Bewertung der kardialen 
Insulinsensitivität in das Perfusionssystem gegeben. Herzfunktion und -leistung wurden 
kontinuierlich während der Perfusion aufgezeichnet. Morphologische Parameter der Ratten 
einschließlich Körper- und Herzgewicht wurden protokolliert. Die enzymatische Aktivität der 
Carnitin-Palmitoyltransferasen I und II, isoliert aus Herzgewebe, wurden 
spektrophotometrisch bestimmt. 
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Ergebnisse: Das Körpergewicht von LCR Ratten war signifikant größer im Vergleich zu 
HCR Ratten. Eine ähnliche Tendenz zeigte sich für das Herzgewicht. Die ex vivo während der 
Herzperfusion gemessene Herzleistung war weder in der akuten Sepsis noch in Sepsis-
Überlebenden beeinträchtigt und hing nicht von der intrinsischen Leistungskapazität ab. LCR 
Herzen neigten verglichen mit HCR Herzen zu einer höheren Glukoseoxidation und einer 
niedrigeren Fettsäureoxidation. Akute Sepsis oder das Überleben einer Sepsis hatten keinen 
wesentlichen Einfluss auf die basale Substratoxidation des Herzens. Die Gabe von Insulin 
provozierte in allen untersuchten Gruppen einen adäquaten Anstieg von Glukoseoxidation und 
einen Abfall der Fettsäureoxidation. Dies weist auf eine erhaltene kardiale Insulinsensitivität 
während und nach einer Sepsis unabhängig von der angeborenen Leistungskapazität hin. Die 
enzymatischen Aktivtäten der Carnitin-Palmitoyltransferasen I und II zeigten sich 24 h nach 
Sepsisinduktion nicht verändert und unterschieden sich nicht zwischen HCR und LCR 
Herzen. 
 
Schlussfolgerung: Die Sepsis zeigte in dieser Studie keine wesentlichen Auswirkungen auf 
Herzstoffwechsel oder -leistung. Die genetische Prädisposition für intrinsische 
Leistungskapazität hatte weder während der akuten Sepsis noch in Sepsis-Überlebenden 
signifikanten Einfluss auf die kardiale Substratoxidation. Damit können die in unserem 
Sepsis-Model präsente hohe Mortalität und die ausgeprägte gesundheitliche Beeinträchtigung 
nicht auf Dysfunktionen des kardialen Stoffwechsels oder der kontraktilen Herzfunktion 
zurückgeführt werden. Die Mechanismen, die den signifikanten Überlebensvorteil von HCR 
Ratten gegenüber LCR Ratten 24 h nach Sepsisinduktion vermitteln, bleiben weiterhin unklar. 
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1 Introduction 
1.1 Sepsis and septic cardiomyopathy 
While the origins of the term sepsis can be traced back to ancient times, it was the German 
physician Hugo Schottmüller who introduced the first modern definition of sepsis, 
recognizing bacterial infection as an essential part of the disease (Schottmüller 1914): "Sepsis 
is present if a focus has developed from which pathogenic bacteria, constantly or periodically, 
invade the blood stream in such a way that this causes subjective and objective symptoms." 
Since then, our knowledge about pathomechanisms and nature of sepsis steadily increased and 
new definitions evolved over time. The most recent was developed by an international task 
force in 2016 (sepsis-3), defining sepsis as life-threatening organ dysfunction caused by a 
dysregulated host response to infection (Singer et al. 2016). Thereby, not only the infection 
but also the overshooting inflammatory host response and consecutive organ dysfunction 
characteristic for sepsis were accounted for.  
Despite immense scientific efforts to combat the detrimental consequences of septic 
infections, sepsis remains a major health issue on national and global level. In 2013, 279530 
cases of sepsis were registered in German hospitals (Fleischmann et al. 2016). The in-hospital 
mortality was determined as 24.3%, corresponding to 67849 sepsis-associated deaths. In 
comparison to 2007, the incidence of sepsis rose by an average of 5.7% per year. Alarmingly, 
mortality only dropped by a total of 2.7% over the same period. A comparable trend was 
reported by the National Center for Health Statistics for the USA, underlining the 
international relevance of sepsis (Hall et al. 2011). The annual incidence of sepsis rose by 
70% from 22.1 per 10000 in 2000 to 37.7 per 10000 in 2008.  
Sepsis can interfere with the function of a variety of organ systems, including the heart. 
Manifestation of septic cardiomyopathy (SCM), broadly defined as an acute syndrome of 
cardiac dysfunction in patients with sepsis (Beesley et al. 2018), is considered a serious 
complication. The prevalence of SCM varies around 50% depending on the method applied to 
identify cardiac dysfunction. Early studies defined SCM as a depression of left ventricular 
ejection fraction (LVEF) concomitant with ventricular dilation (Parker et al. 1984). However, 
LVEF is influenced by several factors, such as cardiac filling pressure and afterload, and may 
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not reflect intrinsic cardiac function. Additionally, LVEF was found to be a poor predictor of 
mortality in septic patients (Sevilla Berrios et al. 2014). Recently, longitudinal strain, a 
measure of the deformation of the myocardium detected by echocardiography, was suggested 
to be a more sensitive parameter for cardiac dysfunction compared to LVEF (Stanton et al. 
2009). Indeed, pathologic left ventricular longitudinal strain was found in septic patients and 
correlated significantly with mortality (Palmieri et al. 2015). Regardless of the diagnostic tool, 
most studies associate SCM to a worse outcome of sepsis. 
The causative mechanisms involved in the development of SCM are under constant debate. A 
variety of chemical mediators has been proposed to induce SCM. Tumor necrosis factor alpha 
and interleukin 1 beta, cytokines significantly up-regulated in acute sepsis, were shown to 
depress myocardial cell contractility with a synergistic effect in vitro (Kumar et al. 1996). 
Oxidative damage due to increased production of reactive oxygen species was linked to 
compromised cardiac function in sepsis (Tsolaki et al. 2017, Khadour et al. 2002). 
Furthermore, excess production of nitric oxide caused by elevated levels of inducible nitric 
oxide synthase was associated to cardiac impairment in septic animal models (Khadour et al. 
2002, Preiser et al. 2001). Unfortunately, the suggested mechanisms did not translate into 
improvements of clinical therapy yet, hinting on additional factors contributing to the 
manifestation of SCM. So far, alterations of cardiac substrate metabolism in SCM have been 
rather neglected. Since cardiac function and oxidative substrate metabolism are inextricably 
linked, potential disturbance of metabolic pathways in the septic heart may lead to mechanical 
dysfunction. Thus, a better understanding of cardiac metabolism in sepsis is mandatory and 
may grant access to new therapeutic strategies.  
1.2 Genetic predisposition for intrinsic exercise capacity  
Development and outcome of diseases are determined by a plethora of extrinsic and intrinsic 
factors. Among the intrinsic, the genetic predisposition for exercise capacity appears to play 
an interesting role. In order to study intrinsic exercise capacity under controlled and 
reproducible conditions, Britton and Koch generated an innovative rat model (Koch et al. 
1998, Koch und Britton 2001). Outbred N:NIH rats were tested for their running performance 
on a treadmill. Based on the results, the highest-performing rats and lowest-performing rats 
were selected and bred separately. Repetition of this strategy for more than 20 generations led 
to two populations (high capacity runners, HCR, and low capacity runners, LCR)  
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substantially differing in their physical exercise capacity (Figure 1), illustratively measured as 
distance run to exhaustion, maximal speed and time run to exhaustion (Schwarzer et al. 2010).  
 
 
 
 
Figure 1: Exercise performance assessed in HCR and LCR rats after 22 generations of divergent selection. 
HCR – high capacity runners, LCR – low capacity runners (Schwarzer et al. 2010). 
 
Besides differences in physical endurance, HCR and LCR rats showed divergent 
characteristics in several other domains. Interestingly, low intrinsic exercise capacity was 
associated to a decreased lifespan compared to high exercise capacity (Koch et al. 2011). 
Blood pressure, fasting glucose, serum insulin, serum triglycerides and free fatty acids were 
significantly increased in LCR compared to HCR, indicating an unfavorable cardiovascular 
and metabolic phenotype (Wisloff et al. 2005). LCR rats exhibit systemic insulin resistance 
(IR), most pronounced after challenge with high-fat diet (Bikman et al. 2009, Noland et al. 
2007). In a study investigating nociception, HCR displayed higher pain thresholds, indicating 
a lower susceptibility to painful stimuli compared to LCR (Geisser et al. 2008). 
1.3 Influence of intrinsic exercise capacity on sepsis survival 
As demonstrated, HCR/LCR represents a complex genetic model for intrinsic exercise 
capacity which results in divergent phenotypes. We questioned how the genetic predisposition 
for intrinsic fitness would influence the development and outcome of a complex disease, such 
as sepsis. In a pilot study, sepsis was induced in male HCR and LCR rats by intraperitoneal 
injection of a pooled human stool sample. The animals were closely monitored for signs of 
illness and death to perform a survival analysis. Indeed, 24 h after sepsis induction HCR rats 
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presented with a significant advantage in survival compared to LCR (Figure 2). However, this 
advantage was blunted 72 h after sepsis induction and total mortality appeared indifferent.  
 
 
 
Figure 2: Influence of intrinsic exercise capacity on sepsis survival. High capacity runners (HCR, ) and 
low capacity runners (LCR, ). Log-rank test. Unpublished data.  
 
The reasons for the significant advantage in survival 24 h after sepsis induction for HCR rats 
were not apparent. We decided to follow-up on these interesting findings and hypothesized 
that impairment of cardiac function or perturbance of cardiac substrate metabolism during the 
acute phase of sepsis may be of importance for the observed difference in survival.  
1.4 Cardiac substrate metabolism in health and disease 
The heart relies on a continuous and efficient supply of adenosine triphosphate (ATP) to 
sustain mechanical function. Physiologically, ATP formation in adult cardiomyocytes is 
predominantly fueled by oxidation of fatty acids (Neely und Morgan 1974, Saddik und 
Lopaschuk 1991, Doenst et al. 2013). However, the heart is characterized by substantial 
metabolic flexibility and was therefore aptly considered an ‘omnivore’ (Taegtmeyer und 
Lubrano 2014). Dependent on metabolic regulation and availability of resources, cardiac 
substrate preference may shift from fatty acid towards glucose consumption, and other 
substrates, such as lactate, pyruvate or ketone bodies, may contribute to cardiac ATP 
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formation to a larger extent. This versatility guarantees sufficient cardiac energy supply under 
varying conditions and ensures maintenance of contractile function. 
Interestingly, different types of cardiac disease, e.g., ischemic heart failure, are accompanied 
by derangements of cardiac substrate metabolism and restriction of metabolic flexibility 
(Doenst et al. 2013, Karwi et al. 2018). In the failing heart, compromised mitochondrial 
function and impaired oxidative phosphorylation lead to a lack of ATP production (Neubauer 
2007). While oxidation of fatty acids is the main source of ATP generation in the healthy 
heart, the majority of studies report a decrease of  fatty acid oxidation already in early stages 
of heart failure (Doenst et al. 2010, Akki et al. 2008). Similarly, glucose oxidation was 
observed to be decreased in several models of heart failure (Zhabyeyev et al. 2013, Mori et al. 
2012). However, the findings were inconsistent as some studies reported unchanged or 
increased rates of glucose oxidation (Doenst et al. 2010, Karwi et al. 2018). The general 
decline of oxidative ATP production was, in many cases, met by a shift towards anaerobic 
metabolism, i.e., flux through anaerobic glycolysis was elevated in hypertrophic hearts 
(Allard et al. 1994, Riehle et al. 2011).  
Thus, pathological alterations of cardiac function and structure are associated to profound 
metabolic remodeling. Unfortunately, studies addressing metabolic changes and cardiac 
substrate preference in septic hearts are scarce and conflicting. In C57BL/6 mice subjected to 
injection of LPS to induce endotoxemia, palmitate oxidation was significantly depressed 
(Drosatos et al. 2011). In a similar model, both fatty acid oxidation and glucose oxidation 
were markedly suppressed after LPS administration (Drosatos et al. 2013). In contrast, 
fractional contribution of fatty acid oxidation to ATP production was increased in mice 24h 
after sepsis induction by cecal ligation and puncture (Standage et al. 2017). Additional 
investigations focusing on cardiac substrate metabolism and metabolic regulation are required 
to gain a better understanding of the pathophysiology of septic cardiomyopathy. 
1.5 Cardiac metabolic regulation by insulin 
Cardiac substrate metabolism is controlled by a plethora of mechanisms. Amongst hormonal 
regulators, insulin represents one of the most influential factors for cardiac substrate selection 
(Bertrand et al. 2008). After binding of insulin to the extracellular part of the insulin receptor, 
a cascade of reactions is activated. In brief, binding of insulin prompts the 
autophosphorylation of the insulin receptor and phosphorylation of further substrates, such as 
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insulin receptor substrate and Shc. Consequential, phosphatidylinositol 3-kinase (PI3K) is 
activated. PI3K phosphorylates phosphatidylinositol (4,5)-bisphosphate to phosphatidyl- 
inositol (3,4,5)-trisphosphate which recruits and activates phosphoinositide-dependent 
kinase 1 and protein kinase B/Akt. The colocalization and action of the latter ultimately 
provokes a series of metabolic effects. First, glucose transporter 4 (GLUT4) is translocated 
from intracellular vesicles to the sarcolemmal membrane, enabling increased glucose uptake 
into the cardiomyocytes. Second, insulin signaling stimulates the synthesis of fructose 2,6-
bisphosphate, a key activator of phosphofructokinase-1, leading to higher flux through 
glycolysis (Bertrand et al. 2008). As glucose utilization is favored after insulin stimulation, 
fatty acid oxidation contributes less to ATP production.  
Some evidence suggests interference of the inflammatory milieu present in sepsis with 
systemic insulin signaling. Various studies reported systemic insulin resistance in the context 
of sepsis and endotoxemia (Illuri et al. 2016, Marik und Raghavan 2004, Agwunobi et al. 
2000). Importantly, the finding of systemic insulin resistance does not necessarily translate to 
insulin resistance of cardiomyocytes. Indeed, most experiments primarily demonstrated 
impaired insulin signaling in peripheral tissues, such as skeletal muscle, adipose tissue or liver 
(Bierbrauer und Weber-Carstens 2011, McCowen et al. 2001). In open-chest pentobarbital 
sodium-anesthetized dogs, cardiac insulin sensitivity was found to be reduced in 
hyperinsulinemic-euglycemic clamp experiments after endotoxin administration (Raymond et 
al. 1988). Likewise, bacterial endotoxin injection in rats induced a reduction of cardiac 
glycolysis and glycogen synthesis after insulin stimulation compared to control, indicating 
endotoxin mediated insulin resistance (Tessier et al. 2003). Admittedly, both studies used the 
rather artificial experimental setup of direct LPS infusion to generate endotoxemia. Therefore, 
it remains of great interest if impaired cardiac insulin signaling is also present in more 
physiological models of sepsis.   
1.6 Carnitine palmitoyltransferases I and II  
While glucose utilization is in part directed by insulin signaling, different mechanisms apply 
on the regulation of fatty acid oxidation. An essential and rate-limiting step of oxidative fatty 
acid metabolism is the transfer of activated fatty acids into the mitochondrial matrix, the 
cellular compartment containing the enzymatic machinery required for β-oxidation. This 
transport is facilitated by an enzyme system involving carnitine palmitoyltransferase I and II 
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(CPT I and CPT II) (Park und Cook 1998). After incorporation of fatty acids into the cytosol, 
they are activated to acyl-CoA thioesters by acyl-CoA synthetase. CPT I, located in the outer 
mitochondrial membrane, transfers the acyl groups from CoA to carnitine to produce 
acylcarnitine (Figure 3). Acylcarnitine is transported into the mitochondrial matrix in 
exchange for free carnitine by carnitine-acylcarnitine translocase. Finally, CPT II, located in 
the inner mitochondrial membrane, reconverts acylcarnitine to acyl-CoA to complete the 
transfer. As for enzymatic regulation, malonyl-CoA, a substrate for fatty acid synthase and 
indicator of high levels of acetyl-CoA, represents a potent inhibitor of CPT I specifically 
(Paulson et al. 1984). Thus, fatty acid oxidation is limited in situations of energy overload and 
metabolic efficiency is improved. 
 
 
 
 
Figure 3: Carnitine palmitoyltransferase system. CPT I – carnitine palmitoyltransferase I, CPT II - carnitine 
palmitoyltransferase II, yellow ellipse represents carnitine-acylcarnitine translocase. 
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Interestingly, CPT I activity appears to be affected by inflammatory mediators. Suckling rats 
received LPS intraperitoneally to induce neonatal endotoxemia. As a consequence, cardiac 
CPT I activity was significantly decreased, possibly due to increased nitration of the CPT I 
enzyme (Fukumoto et al. 2002, Eaton et al. 2003). Further experiments are mandatory to 
determine if the observed effects are also present in adult organisms and to confirm the results 
in different models of sepsis. 
1.7 Investigation of cardiac metabolism using radioactive tracer methods 
The assessment of cardiac substrate oxidation requires advanced techniques. One approach to 
determine metabolic flux rates in the heart is the use of instable, radioactive tracers 
(Taegtmeyer et al. 2016). In principle, stable atoms of energy-providing substrates are 
replaced by radioactive isotopes, such as 14C, 3H or 32P. When labeled substrates are 
metabolized, new labeled metabolites and metabolic byproducts are formed which can be 
analyzed and quantified to estimate flux through the respective pathway. While radioactive 
tracers can be used in a broad range of test systems, only the application in isolated beating 
heart experiments allows the cardiac-specific determination of substrate oxidation 
independent of the remaining organism. For that reason, a variety of tracer protocols for 
isolated perfused heart experiments have been established and successfully applied over the 
past decades (Goodwin et al. 1998, Doenst et al. 1999).     
In this study, we used [U-14C]-glucose and [9,10-3H]-oleate to assess oxidative cardiac 
substrate metabolism (Goodwin et al. 1998, Nguyen et al. 2015). After uptake into the cell, 
[U-14C]-glucose is metabolized to [U-14C]-pyruvate by glycolysis which is transported into 
the mitochondrion (Figure 4). Here, [U-14C]-pyruvate is decarboxylated to [U-14C]-acetyl-
CoA by pyruvate dehydrogenase, resulting in the release of 14C-labeled CO2. During the 
oxidation of [U-14C]-acetyl-CoA within the tricarboxylic acid cycle, another two 14CO2 
molecules are liberated. Isolation and quantification of the released 14CO2 allows the 
calculation of absolute glucose oxidation. 
In an initial cytosolic reaction, [9,10-3H]-oleate is activated to [9,10-3H]-oleyl-CoA. 
Hereafter, the activated compound is transported over the mitochondrial membrane by action 
of carnitine palmitoyltransferases I and II, the rate-limiting step of fatty acid oxidation. In the 
mitochondrion, [9,10-3H]-oleyl-CoA is broken down to acetyl-CoA units by β-oxidation. This 
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process leads to the release of 3H-labeled water. Isolation and quantification of 3H20 enables 
the estimation of absolute oleate oxidation. 
 
 
 
 
Figure 4: Biochemistry of the radioactive tracers [U-14C]-glucose and [9,10-3H]-oleate. CoA – coenzyme A, 
PDH – pyruvate dehydrogenase, CPT I/II – carnitine palmitoyltransferase I and II, TCA – tricarboxylic acid. 
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2 Aims of the study 
The molecular features of SCM or septic effects on cardiac metabolism in general have not 
been completely characterized and understood. Initial survival experiments with HCR and 
LCR rats demonstrated that high intrinsic exercise capacity is associated to a significant 
advantage in survival in the first phase of sepsis, i.e., 24 h hours after sepsis induction. The 
reasons responsible for the improved survival remained elusive. 
 
Based on the current lack of knowledge, we addressed the following questions in the present 
study: 
 
• Does the genetic predisposition for intrinsic exercise capacity influence 
cardiac glucose and fatty acid metabolism during acute sepsis?  
 
• Does sepsis induce changes in cardiac insulin sensitivity in dependence of 
exercise capacity? 
 
• Are cardiac CPT I and II activities affected by the inflammatory milieu in 
septic animals? 
 
• Are cardiac performance and mechanical function compromised 24h after 
sepsis induction? 
 
• Are permanent changes of cardiac metabolism and function present in sepsis 
survivors? 
 
 
A better understanding of potential cardiac metabolic and functional alterations induced by 
sepsis might open new perspectives on future therapy strategies and treatment regimens.  
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3 Materials  
3.1 Reagents 
Reagent Source of supply 
5,5'-dithiobis-2-nitrobenzoic acid Sigma 
1-X8 resin chloride form Bio-Rad Laboratories 
Benzethonium hydroxide Sigma 
Bovine serum albumin Sigma 
Bovine serum albumin protein standard Sigma 
Calcium chloride Merck 
L-carnitine Sigma 
Dihydrogen potassium phosphate Merck 
EDTA Roth 
Glucose Sigma 
[U-14C]-glucose Perkin-Elmer 
Heparin-Natrium-25000 Ratiopharm 
HEPES Sigma 
Insulin (Insuman® Rapid) Sanofi-Aventis 
Magnesium chloride Sigma 
Magnesium sulfate Merck 
Malonyl-Coenzyme A Sigma 
Methanol Roth 
[9,10-3H]-oleic acid Perkin-Elmer 
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Palmitoyl-Coenzyme A Sigma 
Perchloric acid Merck 
Potassium chloride Roth 
Protein Assay Dye Reagent   Bio-Rad Laboratories 
Sodium bicarbonate Roth 
Sodium chloride Roth 
Sodium oleate Sigma 
Sodium thiopental Inresa 
Tris-Base Roth 
Tris-Cl Roth 
Triton™ X-100 Sigma 
Ultima Gold™ scintillation cocktail PerkinElmer 
 
3.2 Devices 
Device Source of supply 
Multipurpose scintillation counter LS 6500 Beckman 
Centrifuge 5804 R Eppendorf 
Sonicator UW 2070 BANDELIN electronic 
Synergy 2 Multi-Mode Microplate Reader BioTek Instruments 
Teflon homogenizer RE 16 IKA-Labortechnik 
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3.3 Perfusion apparatus 
Device Source of supply 
Pressure transducer and recording system Millar Instruments 
Perfusion glassware 
 
P.A. Brooks, Prototype Scientific 
Glass Blower 
Tygon™ tubing 3.2 mm x 0.8 mm, 15 m Saint Gobain 
Tygon™ tubing 6.4 mm x 1.6 mm, 15 m Saint Gobain 
Glass Fiber filter APFD04700 Millipore 
Mixed cellulose esters membrane SMWP04700 Millipore 
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4 Methods 
4.1 Animal model 
4.1.1 High and low capacity runners (HCR/LCR) 
Rats selectively bred for high (HCR) and low capacity running (LCR) have been obtained 
from Steve Britton and Lauren Koch, Department of Anesthesiology, University of Michigan, 
Ann Arbor, Michigan, USA. The animals have been bred and housed at the Department of 
Laboratory Animal Science, University Jena, Germany under artificial day-night conditions 
(12 h light, 12 h dark) at room temperature. Water and food were available ad libitum. All 
experiments were approved by the regional animal welfare committee and were performed 
according to the German legislation on protection of animals. 
4.1.2 Induction of sepsis 
Sepsis was induced in male HCR and LCR rats at the age of 15 ± 1 weeks using a 
standardized peritoneal contamination and infection model (Gonnert et al. 2011, Chung et al. 
2017). Under mild anesthesia (isoflurane 2%), a stool suspension (0.8 µl/g body weight) was 
injected intraperitoneally into the right lower quadrant of the abdomen with a 21-gauge 
cannula. The stool suspension derived from pooled human stool samples was provided by the 
Department of Experimental Anesthesiology, University Hospital Jena, Germany.  
4.1.3 Clinical severity score  
After induction of sepsis, the animals were monitored using the clinical severity score (CSS), 
an assessment system developed previously (Gonnert et al. 2011). The CSS considers 
spontaneous activity, reaction to exogenous stimuli and posture to evaluate the clinical status. 
Table 1 lists the assessed items in detail. 
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Table 1: Clinical severity score (CSS) for the assessment of the clinical status (Gonnert et al. 2011). 
Grade Criteria 
 Spontaneous activity Reaction to exogenous stimuli Posture 
1 Active, strong Curious, quick movements Normal 
2 
Less active with occasional 
interruptions in activity 
Reduced alertness, but adequate 
response 
Slightly hunched 
3 
Slow, sleepy moves with 
difficulty 
Limited and delayed Hunched 
4 
Lethargic, motionless, no 
movement 
None Severely hunched 
 
4.2 Isolated working rat heart perfusion 
4.2.1 Isolated working rat heart preparation 
Hearts of HCR and LCR rats were perfused before sepsis induction (control) as well as  
24-36 h, 4-5 d and 4-5 w after sepsis induction. The set of perfusions performed after 24-36 h 
was meant to assess acute changes of cardiac metabolism and ex vivo cardiac performance 
during sepsis. Experiments after 4-5 d and 4-5 w addressed potential intermediate- and long-
term alterations of cardiac substrate utilization and function in sepsis survivors. Isolated 
working rat hearts were prepared as described previously with some modifications (Doenst et 
al. 1998, Doenst et al. 1999). Rats were anesthetized with sodium thiopental (5 mg/100g body 
weight, intraperitoneal injection). When deep anesthesia was ensured, a transverse abdominal 
cut was done to expose the inferior vena cava. 200 IU heparin were injected into the inferior 
vena cava. Median sternotomy was followed by rapid excision of the heart-lung-package. 
Immediately after excision, the heart was placed in ice-cold Krebs-Henseleit (KH) buffer 
(128 mM NaCl, 5 mM KCL, 1 mM KH2PO4, 1.3 mM MgSO4, 15 mM NaHCO3, 
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2.5 mM CaCl2) to prevent ischemic damage. The aorta was freed from excess tissue and 
cannulated. A brief period of retrograde perfusion (Langendorff mode) allowed to wash out 
any blood remaining in the heart and to cannulate the left atrium. After successful 
cannulation, the hearts were placed in the heart chamber connected to a compliance unit and 
perfused as working hearts with recirculating KH medium containing glucose (5 mM) and 
sodium oleate (0.4 mM) bound to 1% BSA. Figure 5 schematically demonstrates the 
experimental setup. The perfusion medium was equilibrated with 95% O2 – 5% CO2. 
Temperature was maintained at 37°C. A preload of 15 cmH2O and an afterload of 100 cmH2O 
were guaranteed for all experiments. Hearts were beating spontaneously without requirement 
of a pacemaker. Body weights and organ weights were recorded. 
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Figure 5: Experimental setup of the isolated working rat heart. H – heart chamber with isolated working 
heart, C – compliance unit, T – pressure transducer and recording system, R – reservoir for perfusion medium,  
P – pump to recirculate medium, O – oxygenator. Arrows hint on the direction of flow. Preload (15 cm H2O) and 
afterload (100 cm H2O) are indicated. 
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4.2.2 Measurement of cardiac performance 
Cardiac mechanical function, including heart rate and left ventricular contractility (+dP/dt), 
was monitored continuously by a pressure transducer connected to a recording system (Millar 
Instruments, Houston). Aortic and coronary flow were measured every 5 min by timing the 
rise of the respective fluid meniscus in calibrated sections of the perfusion system. Cardiac 
power was calculated according to the basic physical principle: 
 
𝑃 =
𝑊
𝑡
=  𝑝 ∗ ?̇? 
 
(P – cardiac power, W – mechanical work, t - time, p – arterial pressure, ∆?̇? – cardiac output). 
 
The arterial pressure equals the afterload which is maintained at 100 cmH2O constantly. 
Cardiac output was calculated by addition of aortic and coronary flow (Doenst et al. 1998, 
Doenst et al. 1999). Thus, the equation simplifies to 
 
𝑃 =
?̇?𝑎𝑜𝑟𝑡𝑖𝑐 + ?̇?𝑐𝑜𝑟𝑜𝑛𝑎𝑟𝑦
6.12
 
 
(P – cardiac power [mW], ?̇?𝑎𝑜𝑟𝑡𝑖𝑐  – aortic flow [ml/min],  ?̇?𝑐𝑜𝑟𝑜𝑛𝑎𝑟𝑦 – coronary flow [ml/min], 
6.12 – correction factor accounting for the constant arterial pressure and unit conversions 
[m2/N]). 
4.2.3 Perfusion protocol 
Hearts were perfused for 60 min with Krebs-Henseleit buffer containing glucose (5 mM) and 
sodium oleate (0.4 mM) bound to 1% BSA. After an initial phase of perfusion to ensure 
stabile mechanical function, 60 µl of [U-14C]-glucose and 5 µl of [9,10-3H]-oleate were added 
to the perfusion system to start the experiment. Beginning at t = 0 min, 2 ml aliquots of 
perfusion medium were withdrawn for later determination of glucose and fatty acid oxidation 
every 5 min. Similarly, the gaseous 14C-CO2 derived from glucose oxidation was collected in 
5 min intervals by trapping in benzethonium hydroxide. After 30 min, insulin (0.5 IU/l) was 
added to the perfusion medium. Thus, the first 30 min of the experiment provided information 
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about the basal cardiac substrate oxidation. The second half of the perfusion protocol were 
dedicated to investigate insulin stimulated metabolic conditions. Figure 6 illustrates the 
applied protocol. At the end of the perfusion, hearts were frozen in liquid nitrogen for further 
analysis. 
 
 
 
 
Figure 6: Perfusion protocol. After an initial phase allowing functional stabilization, labeled substrates were 
administered to examine cardiac metabolism under basal conditions. At t = 30 min, insulin was added to 
investigate cardiac metabolism after stimulation. KH buffer – Krebs-Henseleit buffer. 
4.3 Radioisotopic techniques 
4.3.1 Determination of glucose oxidation 
The oxidation of [U-14C]-glucose by pyruvate dehydrogenase and the citric acid cycle during 
the isolated working heart perfusion leads to a release of 14CO2. The measurement of 
14CO2 at 
consecutive time points of the perfusion protocol combined with knowledge about the total 
specific activity of the system allows the estimation of glucose oxidation in absolute values. 
The whole perfusion system was rendered gas tight and the gaseous 14CO2 was channeled into 
a scintillation vial containing 5 ml of benzethonium hydroxide solution (333 mM, diluted with 
methanol) which is able to bind 14CO2. After addition of 5 ml of scintillation cocktail, the 
samples were mixed and activity was measured using a liquid scintillation counter.  
To determine the amount of 14CO2 solved in the perfusion, a scintillation vial was prepared 
with 1 ml of benzethonium hydroxide solution for each sample. 0.5 ml of sample drawn from 
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the perfusion system were transferred into a 1.5 ml tube which was cautiously placed inside 
the scintillation vial without spilling any of the content. The vial was sealed gas tight with a 
rubber plug. 0.1 ml of perchloric acid were injected into the sample through the plug without 
compromising the seal. The acidification of the sample promotes the shift of 14CO2 from the 
aqueous to the gaseous phase and enables the binding to benzethonium hydroxide.  After 
incubation for 12 h on a shaker adjusted to medium speed, the rubber plug and the 1.5 ml tube 
containing the sample were carefully removed. Finally, 4 ml of scintillation cocktail were 
added to the scintillation vial and activity was measured using a liquid scintillation counter 
after mixing. Combination of the activity determined in the aqueous and gaseous phase allows 
the calculation of total glucose oxidation: 
 
𝐺𝑂 =  
∆(𝐴𝑎𝑞𝑢𝑒𝑜𝑢𝑠 + 𝐴𝑔𝑎𝑠𝑒𝑜𝑢𝑠)
𝐴𝑠𝑝𝑒𝑧 ∗ 𝑚𝑑𝑟𝑦
 
 
(GO – glucose oxidation [µmol/min/g dry weight], ∆A – shift in activity over time [cpm/min], 
Aspez – specific activity of the medium [cpm/µmol glucose], mdry – cardiac dry weight [g]). 
 
The complete aerobic oxidation of 1 mol of glucose generates 4 mol of ATP, 10 mol of 
NADH and 2 mol of FADH2. Assuming an ATP yield of 2.5 mol ATP/NADH and 1.5 mol 
ATP/FADH2 (Hinkle 2005), the breakdown of 1 mol of glucose generates a total of 32 mol of 
ATP. Thus, ATP production derived from GO was calculated as GO [µmol/min/g dry weight] 
* 32. 
4.3.2 Determination of fatty acid oxidation 
During the breakdown of [9,10-3H]-oleate by beta-oxidation, 3H-labeled water is liberated. 
The measurement of 3H2O at consecutive time points of the perfusion protocol combined with 
knowledge about the total specific activity of the system allows the estimation of beta-
oxidation in absolute values. Samples of the perfusion medium were obtained every 5 min. To 
quantify 3H2O, the labeled water was separated from all other radioactive molecules in the 
medium. Filter columns were made by preparation of 1 ml syringes with glass fiber pads and 
0.5 ml of a filter resin. The columns were washed with 0.5 ml of water twice. Then, 0.1 ml of 
sample were added followed by two further elution steps with 0.1 ml and 0.7 ml of water, 
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respectively. The elute was saved in a scintillation vial. After addition of 3 ml of scintillation 
cocktail, the samples were vortexed.  
To determine the total specific activity of the perfusion medium, 0.1 ml of three different 
samples were mixed with 3 ml of scintillation cocktail without prior filtration. Finally, the 
activity of all prepared samples was determined using a liquid scintillation counter. Oleic acid 
oxidation was calculated as: 
 
𝐹𝐴𝑂 =  
∆𝐴
𝐴𝑠𝑝𝑒𝑧 ∗ 𝑚𝑑𝑟𝑦
 
 
(FAO – fatty acid oxidation [µmol/min/g dry weight], ∆A – shift in activity over time [cpm], 
Aspez – specific activity of the medium [cpm/µmol oleic acid], mdry – cardiac dry weight [g]). 
 
The complete breakdown of 1 mol of oleic acid by beta-oxidation generates 9 mol of acetyl-
CoA, 8 mol of NADH and 7 mol of FADH2. The oxidation of 9 mol of acetyl-CoA in the 
citric acid cycle yields 9 mol of ATP, 27 mol of NADH and 9 mol of FADH2. Assuming an 
ATP yield of 2.5 mol ATP/NADH and 1.5 mol ATP/FADH2 (Hinkle 2005), the oxidation of 
1 mol of oleic acid generates a total of 120.5 mol of ATP. Since 2 ATP are required to 
activate oleic acid to oleyl-CoA at the beginning of beta-oxidation, the net ATP production 
equals 118.5 mol of ATP. Thus, ATP production derived from FAO was calculated as FAO 
[µmol/min/g dry weight] * 118.5. 
4.4 Tissue chemistry and photometric methods 
4.4.1 Carnitine palmitoyltransferase I/II activity 
Carnitine palmitoyltransferase I and II (CPT I and CPT II) activities were measured in cardiac 
extracts as described previously with some modifications (Bieber et al. 1972). The fusion of 
L-carnitine and palmitoyl-CoA to palmitoylcarnitine catalyzed by CPT I and CPT II liberates 
Coenzyme A which reacts with 5,5'-dithiobis-2-nitrobenzoic acid (DTNB) stoichiometrically 
to produce mercaptide anions. The generated mercaptide anions were detected 
spectrophotometrically at 412 nm. To distinguish between CPT I and CPT II activity, 
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malonyl-CoA was added to the reaction mix after total CPT activity was determined. The 
difference of total CPT activity and CPT activity after inhibition equals the CPT II activity. 
20 mg of powdered cardiac tissue were homogenized in 200 µl of extraction puffer 
(40 mM HEPES, 1 mM EDTA, 2 mM MgCl2, pH=7.4) for 1 min using a Teflon homogenizer 
at 1000 rpm. Next, each sample was sonicated three times for 10 s (7 cycles, 70% power). 
2 µl of 5% Triton-100 were added and the homogenates were incubated for 5 min on ice after 
mixing. Finally, the samples were centrifuged at 12000 rcf for 5 min at 4°C. The supernatants 
were saved and assayed for CPT activity. 5 µl of undiluted sample were incubated with 185 µl 
of reaction puffer (34 mM HEPES, 99 mM Tris-Cl, 0.08% Triton-100, 1.28 mM EDTA, 
1.35 mM L-carnitine, 0.27 mM DTNB) for 3 min at 25°C. Hereafter, 10 µl of 
0.7 mM palmitoyl-CoA or water were added to start the reaction or as control, respectively. 
The change of absorbance at 412 nm was measured continuously for 8 min before 10 µl of 
0.21 mM malonyl-CoA were added to measure the CPT II activity exclusively. Enzymatic 
activity was calculated based on the law of Lambert-Beer (ε DTNB = 13.9 mM-1cm-1) and 
normalized to cardiac protein concentration. Each sample was measured as triplicate.  
4.4.2 Bradford protein assay 
Protein concentrations of cardiac extracts were measured using the method developed by 
Bradford (Bradford 1976). After binding to protein, the dye Coomassie Brilliant Blue G-250 
contained in the reaction mix changes its color to blue and is detected spectrophotometrically 
at 595nm. Cardiac extracts were diluted 20-fold. The Protein Assay Dye Reagent provided by 
Bio-Rad was diluted 5-fold. 5 µl of sample were mixed with 200 µl of the diluted dye. After 
incubation for 3 min at room temperature, the absorbance at 595 nm was measured with a 
Synergy 2 Multi-Mode Microplate Reader (BioTek Instruments). Protein concentrations were 
calculated based on a standard curve derived from a freshly prepared BSA protein standard. 
All samples were measured as triplicates. 
4.4.3 Cardiac dry weight 
Cardiac power, glucose oxidation and fatty acid oxidation were normalized to cardiac dry 
weight. About 100 mg of powdered heart sample were incubated for 48 h at 72°C to evaporate 
any water present. Hereafter, the weight of each sample was recorded and the obtained wet-
dry ratio was used to calculate cardiac dry weight.  
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4.5 Statistical analysis 
Comparison of means was performed using two-way analysis of variance (two-way ANOVA) 
and Tukey post hoc test (Prism 7, GraphPad software, Inc.). Differences of means with a p-
value lower than 0.05 were considered statistically significant. Results are presented as mean 
± standard error of the mean. 
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5 Results 
5.1 Morphology  
Body, heart, liver and lung weights of all animals were recorded during the perfusion 
experiment (Figure 7a-d). Animals bred for low intrinsic running capacity (LCR) presented 
with a significantly increased body weight compared to rats with high intrinsic running 
capacity (HCR) at all time points investigated. Heart weights tended to be slightly higher in 
LCR than HCR without reaching statistical significance. Lung weights were equal for all 
groups. Liver weights of LCR control rats were increased compared to HCR but did not differ 
significantly in the remaining groups. The observed increase of body weight in LCR is mainly 
due to enlarged peripheral and visceral adipose tissue depots (not shown).  
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Figure 7: Morphological parameters. Body weight (a), heart weight wet (b), liver weight (c) and lung weight 
(d) of high capacity runners (HCR, ) and low capacity runners (LCR, ) at different time points after sepsis 
induction compared to control. n = 4 for HCR 4-5 d and HCR 4-5 w, n = 7-8 for the remaining groups. Data 
presented as mean ± standard error of the mean. * - p < 0.05, ** - p < 0.01. 
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5.2 Cardiac power 
Cardiac performance parameters have been monitored continuously during isolated working 
heart perfusions using a pressure transducer connected to the perfusion system. Every 5 min, 
cardiac power was assessed and recorded (Figure 8). Baseline cardiac power, measured during 
the first span of the perfusion, did not differ significantly between LCR and HCR rats. 
Administration of insulin did not lead to relevant changes of cardiac function. In HCR, 
cardiac power tended to be decreased 4-5 w after sepsis induction compared to control 
without reaching statistical significance. Sepsis induction did not compromise cardiac 
performance after short-term (24-36 w). 
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Figure 8: Cardiac power of HCR and LCR hearts over time. Cardiac power normalized to cardiac dry weight 
of high capacity runners (HCR) and low capacity runners (LCR) 24-36 h (□), 4-5 d (▲) and 4-5 w (▽) after 
sepsis induction and control (●). Vertical line at t = 30 min indicates administration of insulin. n = 4 for HCR 4-5 
d and HCR 4-5 w, n = 7-8 for the remaining groups. Data presented as mean ± standard error of the mean.  
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5.3 Cardiac performance parameters 
Besides cardiac power, heart rate as well as cardiac contractility were recorded continuously. 
Since administration of insulin did neither affect heart rate nor contractility, the presented data 
represent values averaged over 60 min of perfusion (Figure 9a-c). Similar to cardiac power, 
heart rate was not dependent on intrinsic exercise capacity. Furthermore, sepsis induction did 
not provoke any significant changes in heart rate ex vivo. Cardiac contractility tended to be 
higher both in HCR and LCR 4-5 d after sepsis induction compared to control without 
reaching statistical significance. Taken together, induction of sepsis did not affect cardiac 
mechanical function of isolated working hearts at any given timepoint.  
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Figure 9: Cardiac performance assessed during isolated working heart perfusions. Cardiac power averaged 
over 60 min (a), heart rate (b) and peak ventricular contractility (+dP/dt, c) of high capacity runners (HCR, ) 
and low capacity runners (LCR, ) at different time points after sepsis induction compared to control. n = 4 for 
HCR 4-5 d and HCR 4-5 w, n = 7-8 for the remaining groups. Data presented as mean ± standard error of the 
mean. 
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5.4 Baseline cardiac glucose oxidation 
Cardiac baseline glucose oxidation (GO) was determined based on samples taken from the 
perfusion medium during the first span of the perfusion before administration of insulin. 
Baseline GO tended to be higher in LCR hearts compared to HCR hearts at all investigated 
timepoints (Figure 10). Aerobic glucose utilization appeared to be lowest 24-36 h after sepsis 
induction in HCR as well as LCR. On the other end, baseline GO was highest 4-5 d after 
induction of sepsis in both strains. However, all changes did not reach statistical significance 
compared to control.  
 
C
on
tr
ol
24
 - 
36
 h
4 
- 5
 d
4 
- 5
 w
0.00
0.25
0.50
0.75
1.00
G
lu
c
o
se
 o
x
id
a
ti
o
n
 b
a
se
li
n
e
(µ
m
o
l/
m
in
/g
 d
ry
)
 
 
Figure 10: Baseline cardiac glucose oxidation. Glucose oxidation of high capacity runners (HCR, ) and low 
capacity runners (LCR, ) before administration of insulin at different time points after sepsis induction 
compared to control. n = 4 for HCR 4-5 d and HCR 4-5 w, n = 5 for LCR 4-5 w, n = 6-8 for the remaining 
groups. Data presented as mean ± standard error of the mean. 
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5.5 Insulin stimulated cardiac glucose oxidation 
Insulin stimulated cardiac GO was determined based on samples taken from the perfusion 
medium during the second span of the perfusion after administration of insulin. 
Administration of insulin caused a robust increase of oxidative glucose metabolism in all 
investigated groups (Figure 11a-b). The tendency of increased GO in LCR hearts compared to 
HCR hearts observed at baseline conditions remained after insulin stimulation. The absolute 
change of GO was comparable for all groups independent of intrinsic exercise capacity and 
timepoint after sepsis induction. The results suggest preserved cardiac insulin sensitivity 
during acute sepsis and in sepsis survivors.  
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Figure 11: Cardiac glucose oxidation after administration of insulin. Insulin stimulated glucose oxidation (a) 
and change of glucose oxidation calculated as insulin stimulated minus baseline glucose oxidation (b) of high 
capacity runners (HCR, ) and low capacity runners (LCR, ) at different time points after sepsis induction 
compared to control n = 4 for HCR 4-5 d and HCR 4-5 w, n = 5 for LCR 4-5 w, n = 6-8 for the remaining 
groups. Data presented as mean ± standard error of the mean. 
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5.6 Baseline cardiac fatty acid oxidation 
Cardiac baseline fatty acid oxidation (FAO) was determined based on samples taken from the 
perfusion medium during the first span of the perfusion before administration of insulin. 
While GO was found to be higher in LCR than HCR, FAO tended to be reduced in LCR 
compared to HCR except for hearts perfused 4-5 w after sepsis induction (Figure 12). 
Baseline FAO was highest 4-5 d after induction of sepsis in HCR hearts. The lowest rate of 
FAO was observed in LCR hearts 24-36 h after sepsis induction. All changes in FAO failed to 
reach statistical significance compared to control, indicating that baseline FAO is not altered 
during acute sepsis and in sepsis survivors. 
C
on
tr
ol
24
 - 
36
 h
4 
- 5
 d
4 
- 5
 w
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
O
le
a
te
 o
x
id
a
ti
o
n
 b
a
se
li
n
e
(µ
m
o
l/
m
in
/g
 d
ry
)
 
Figure 12: Baseline cardiac fatty acid oxidation. Baseline fatty acid oxidation of high capacity runners 
(HCR, ) and low capacity runners (LCR, ) at different time points after sepsis induction compared to 
control. n = 4 for HCR 4-5 d and HCR 4-5 w, n = 6-8 for the remaining groups. Data presented as mean ± 
standard error of the mean. 
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5.7 Insulin stimulated cardiac fatty acid oxidation 
Administration of insulin provoked a reduction of FAO in all groups. The tendency of higher 
rates of FAO in HCR hearts relative to LCR hearts was maintained after stimulation with 
insulin (Figure 13). Only 4-5 w after sepsis induction, LCR appeared to oxidize more fat than 
HCR. The absolute change of FAO after insulin stimulation was not significantly different 
between groups. However, the decline of FAO was most pronounced 4-5 w after sepsis 
induction in both HCR and LCR. These findings represent further evidence for 
uncompromised cardiac insulin sensitivity during sepsis and in sepsis survivors. 
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Figure 13: Cardiac fatty acid oxidation after administration of insulin. Insulin stimulated fatty acid 
oxidation (a) and change of fatty acid oxidation calculated as insulin stimulated minus baseline fatty acid (b) of 
high capacity runners (HCR, ) and low capacity runners (LCR, ) at different time points after sepsis 
induction compared to control. n = 4 for HCR 4-5 d and HCR 4-5 w, n = 6-8 for the remaining groups. Data 
presented as mean ± standard error of the mean. 
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5.8 Ratio of glucose oxidation to fatty acid oxidation 
The ratio of glucose oxidation to fatty acid oxidation (GO/FAO) was calculated to visualize 
cardiac substrate preference and selection (Figure 14a-b). At baseline conditions, GO/FAO 
was higher in all LCR groups compared to the corresponding HCR groups, emphasizing that 
LCR hearts rely more on oxidative glucose metabolism than HCR hearts. Administration of 
insulin caused a substantial increase of GO/FAO in all investigated groups. This illustrated an 
adequate response to insulin stimulation independent of intrinsic exercise capacity. Acute 
sepsis or sepsis survival did not appear to impair cardiac insulin sensitivity in our 
experimental model. 
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Figure 14: Ratio of glucose oxidation to fatty acid oxidation. Ratio of cardiac glucose oxidation to fatty acid 
oxidation before (a) and after (b) administration of insulin of high capacity runners (HCR, ) and low capacity 
runners (LCR, ) at different time points after sepsis induction compared to control. n = 4 for HCR 4-5 d and 
HCR 4-5 w, n = 5 for LCR 24-36 h and LCR 4-5 w, n = 6-8 for the remaining groups. Data presented as mean ± 
standard error of the mean. 
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5.9 Cardiac efficiency 
The efficiency of cardiac performance can be described based on the ratio of ATP production 
to cardiac power (Figure 15a-b). Under baseline conditions, HCR and LCR hearts produced 
comparable amounts of ATP per milliwatt of cardiac power. Cardiac efficiency tended to be 
slightly higher 24-36 h after sepsis induction in both HCR and LCR. Sepsis survivors did not 
present with any changes of cardiac efficiency compared to control. The ratio of ATP 
production to cardiac power decreased slightly in all groups but LCR control upon insulin 
administration, indicating improved efficiency of insulin stimulated cardiac function. 
However, all effects failed to reach statistical significance. 
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Figure 15: Cardiac efficiency expressed as ratio of ATP production to cardiac power. Ratios of ATP 
production to cardiac power before (a) and after (b) insulin stimulation of high capacity runners (HCR, ) and 
low capacity runners (LCR, ) at different time points after sepsis induction compared to control. n = 4 for 
HCR 4-5 d and HCR 4-5 w, n = 5 for LCR 24-36 h and LCR 4-5 w, n = 6-8 for the remaining groups. Data 
presented as mean ± standard error of the mean. 
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5.10 Carnitine palmitoyltransferase I and II activity 
Carnitine palmitoyltransferase I (CPT I) and II (CPT II) activities of insulin stimulated cardiac 
samples were determined before and 24 h after sepsis induction (Figure 16). Total CPT 
activity was neither affected by the genetic predisposition for exercise capacity nor by the 
induction of sepsis. CPT I inhibition by malonyl-CoA provoked a comparable decline of 
enzymatic activity in all groups, indicating similar CPT I and CPT II activities in all examined 
samples.  
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Figure 16: Cardiac CPT I and II activities. Cardiac carnitine palmitoyltransferase I (CPT I, ) and II 
(CPT II , ) activities of high capacity runners (HCR) and low capacity runners (LCR) 24 h after sepsis 
induction compared to control. n = 4-7. Data presented as mean ± standard error of the mean. 
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6 Discussion 
The current study is the first to investigate septic effects on cardiac metabolism and function 
in dependence of intrinsic exercise capacity. Basal cardiac substrate oxidation was not 
substantially altered during sepsis or in sepsis-survivors. Cardiac insulin sensitivity appeared 
to be preserved at all investigated time points. Cardiac function assessed ex vivo during 
isolated working heart perfusions was not compromised in acute sepsis or in sepsis-survivors. 
Intrinsic exercise capacity did not influence cardiac metabolism or function in septic animals 
significantly. 
 
Basal glucose and fatty acid oxidation were not changed 24-36 h after sepsis induction or in 
sepsis survivors. Indeed, this finding is in line with the few studies focusing on cardiac 
substrate metabolism in sepsis previously. In male Sprague-Dawley rats, sepsis was induced 
by cecal ligation and puncture (CLP) followed by isolated working heart perfusions 12 - 14 h 
later (Watts et al. 2004). Glucose oxidation, determined by measuring 14CO2 liberated from  
[U-14C]-glucose, and oxygen consumption did not differ between septic hearts and control. 
However, cardiac efficiency was decreased since septic hearts displayed reduced cardiac 
function. Another group induced sepsis in rats by inoculation of a pooled fecal homogenate 
and performed Langendorff perfusions with medium containing 14C-labeled glucose, lactate 
or palmitate 48 h later to assess cardiac substrate oxidation (McDonough et al. 1986). The 
contribution of the three substrates to oxidative ATP formation was comparable in hearts from 
septic and control animals, indicating an unchanged myocardial substrate preference. Lastly, 
endotoxemia was provoked in male Sprague-Dawley rats by intraperitoneal administration of 
lipopolysaccharides (LPS) and isolated working heart perfusions were performed 6 h later 
(Soraya et al. 2016). Glucose metabolism including rates of glucose uptake, glycogen 
synthesis, glycolysis and glucose oxidation were not affected in endotoxemic hearts. 
Interestingly, palmitate oxidation was reduced in endotoxemic hearts, proportional to an 
observed decline in left ventricular function. Thus, unchanged cardiac substrate utilization 
was found in the majority of investigated septic rat models and is supported by our results. 
Intrinsic exercise capacity did not affect cardiac baseline metabolism markedly, independent 
of the timepoint after sepsis induction. However, low capacity runner (LCR) hearts appeared 
to oxidize slightly more glucose than high capacity runner (HCR) hearts. Correspondingly, 
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fatty acid oxidation seemed to be lower in LCR compared to HCR. These patterns of substrate 
preference have not been reported as pronounced in previous sets of HCR and LCR heart 
perfusions (Schwarzer et al. 2010). Here, rates of glucose oxidation were similar for the two 
populations, only fatty acid oxidation appeared slightly lower in LCR compared to HCR. Of 
course, the trends found in the present study may be purely coincidental since the differences 
in glucose and fatty acid oxidation failed to reach statistical significance. However, a recent 
proteomic analysis of HCR and LCR hearts advocated for a possible divergence in substrate 
selection (Burniston et al. 2011). Interestingly, HCR hearts exhibited significant increases of 
enzymes involved in β-oxidation compared to LCR, including short-chain specific acyl-CoA 
dehydrogenase, enoyl-CoA hydratase and hydroxyacyl-CoA dehydrogenase. Comparable 
observations were made on transcriptional level before (Bye et al. 2008). Expression of genes 
encoding enzymes involved in oxidative fatty acid utilization was up-regulated in hearts of 
HCR rats. Moreover, LCR rats expressed higher amounts of genes participating in cardiac 
glucose metabolism. Hence, the tendency of LCR hearts to oxidize more glucose and less 
fatty acids compared to HCR seen in the present study may be more than just coincidence. 
 
Beside basal cardiac metabolism, this study also addressed cardiac insulin sensitivity. All 
hearts challenged with insulin during isolated heart perfusions responded with robust 
increases in glucose oxidation and corresponding decreases in fatty acid oxidation, indicating 
preserved insulin sensitivity. Neither acute sepsis nor sepsis-survival influenced cardiac 
insulin sensitivity. At first glance, this appears surprising because sepsis was associated with 
the development of insulin resistance (IR) before (Marik und Raghavan 2004, Chambrier et 
al. 2000, Agwunobi et al. 2000, Illuri et al. 2016). The mediation of IR in septic conditions 
was mainly attributed to players of the proinflammatory cascade activated during sepsis, such 
as tumor necrosis factor alpha (TNF-α) and interleukin 1, or to the action of endotoxins 
directly. However, cytokine and endotoxin mediated effects on the insulin signaling cascade 
were predominantly observed in hepatocytes or peripheral tissues including skeletal muscle 
and adipose tissue but less in cardiomyocytes (Bierbrauer und Weber-Carstens 2011). In one 
study, LPS were administered intravenously for 74 h in Sprague-Dawley rats to induce 
prolonged endotoxemia (McCowen et al. 2001). Insulin-stimulated tyrosine phosphorylation 
of insulin receptors, insulin receptor substrate (IRS) 1 and -2 and binding of the p85 subunit 
of phosphatidylinositol 3-kinase to IRS-1 were significantly reduced in liver and skeletal 
muscle, demonstrating deficits in early steps of insulin signaling upon endotoxemic challenge. 
In cultured adipocytes, TNF-α treatment provoked an increase of serine phosphorylation of 
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IRS-1 (Hotamisligil et al. 1996). Serine phosphorylation of IRS-1 interferes with the insulin-
stimulated tyrosine phosphorylation of IRS-1 and confers IR. Thus, one must differentiate 
between systemic and cardiac IR assessed in isolated hearts. The presence of systemic 
resistance does not automatically guarantee IR in distinct organs such as the heart. The results 
of the present study suggest that cardiac insulin sensitivity is not compromised within the 
framework of the applied model of sepsis. Testing for systemic insulin sensitivity was not 
within the scope of this project. In perspective, it would be of great interest if our septic 
animal model is characterized by dissociated, organ-specific IR. 
Intrinsic exercise capacity did not affect cardiac insulin sensitivity in the present study. The 
responses of both HCR and LCR hearts to insulin stimulation were comparable independent 
of sepsis or sepsis-survival. This finding is in line with previous experiments. In healthy 21 
week old HCR and LCR rats, cardiac sensitivity to insulin assessed during isolated working 
heart perfusions was indifferent (Schwarzer et al. 2010). The response to insulin measured as 
increase in glucose oxidation was more pronounced in their set of experiments compared to 
our results (∆ glucose oxidation: +0.59 µmol/min/g dry weight vs +0.39 µmol/min/g dry 
weight). However, this may be simply explained by different dosages of insulin used in the 
studies (1 IU/l vs 0.5 IU/l, respectively). Interestingly, low intrinsic exercise capacity was 
associated to systemic IR before (Morris et al. 2009, Noland et al. 2007). Fasting glucose and 
serum insulin levels were significantly higher in LCR rats, indicative of reduced sensitivity to 
insulin (Schwarzer et al. 2010, Wisloff et al. 2005). This is yet another example for the 
presence of dissociated IR that hints on different mechanisms contributing to cardiac IR on 
the one hand and peripheral IR on the other. 
Administration of insulin caused a tendential decrease of the ratio of ATP production to 
cardiac power in the majority of groups, hinting on improved cardiac efficiency. This 
observation is in line with previous findings. In perfusion experiments of HCR and LCR 
hearts, insulin increased cardiac efficiency in both strains (Schwarzer et al. 2010). In general, 
insulin signaling and the concomitant shift from fatty acid oxidation towards glucose 
utilization is considered to decrease cardiac oxygen consumption, reduce mitochondrial 
uncoupling and therefore favor energetic efficiency (Iliadis et al. 2011, Boudina et al. 2007). 
Cardiac efficiency was not disturbed in acute sepsis or in sepsis survivors. While somewhat 
surprising, preserved cardiac efficiency fits well into the overall picture of our model, 
considering the unaffected substrate metabolism, insulin sensitivity and cardiac function in 
septic and post-septic animals. 
 
                                                                                                                                     Discussion 
47 
Cardiac function assessed ex vivo during isolated working heart perfusions was not 
compromised 24-36 h after induction of sepsis or in sepsis survivors independent of intrinsic 
exercise capacity. Cardiac power, heart rate and peak ventricular contractility were 
comparable between all groups. Of course, ex vivo cardiac function does not necessarily 
reflect the in vivo situation. Maintained cardiac performance of isolated working hearts 
primarily demonstrates structural integrity of the heart and hints on the absence of static 
myocardial damage. In vivo, a plethora of factors can influence cardiac mechanical function 
and potentially cause dynamic heart failure. In the context of sepsis, potential 
cardiodepressive effects of inflammatory mediators, such as cytokines or endotoxins, come to 
mind first. When the heart is removed from the inflammatory milieu of sepsis for heart 
perfusions, these influences disappear and cardiac function may normalize. However, we do 
not have evidence that in vivo cardiac performance was compromised in our model of sepsis 
induced by peritoneal contamination and infection (PCI). Echocardiography performed in 
HCR and LCR rats 6 h and 24 h after sepsis induction did not reveal significant reduction of 
cardiac function. This was unexpected since previous studies observed cardiac dysfunction 
after employing the PCI model in a different rat species. In male Wistar rats, sepsis induced 
by PCI provoked decreases of stroke volume, end-diastolic volume and cardiac output 
measured with echocardiography after 6 h (Dyson et al. 2011). After 24 h, these effects were 
still present but to a lesser extent. Importantly, only a subset of rats (55%) was affected by 
cardiac impairment. The remaining animals presented with normal cardiac function or 
alleviated symptoms. Decline in cardiac function was associated to a worse prognosis and 
reduction of stroke volume was determined a robust predictor of outcome (Rudiger et al. 
2013). The PCI model of sepsis had never been applied on HCR and LCR rats before. For 
unknown reasons, the impairment of cardiac function seen in Wistar rats after PCI was not 
reproduced in HCR and LCR strains despite inducing critical illness (assessed using the 
clinical severity score) and causing comparable mortality. 
Other studies using a more popular model of systemic inflammation and endotoxemia 
observed even more pronounced disturbances of cardiac function both in vivo and ex vivo. For 
instance, intraperitoneal LPS injection (10 m/kg) in mice caused a significant reduction of 
cardiac contractility 3 h, 12 h and 24 h after injection (Umbarawan et al. 2017). In Wistar rats, 
intravenous administration of LPS (15 mg/kg) prompted a significant decline of mean arterial 
pressure and peak ventricular contractility after 2 h already (Yang et al. 2018). Sprague-
Dawley rats reacted with profound decreases of ejection fraction and fractional shortening to 
an intraperitoneal LPS (15 mg/kg) challenge, indicating impaired left ventricular function 
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(Unuma et al. 2018). However, direct comparisons of the LPS/endotoxemia models of sepsis 
and PCI are problematic as they differ in several points. LPS treatment caused significant 
higher TNF-α levels, responses to oxidative stress and degree of cell death than polymicrobial 
sepsis induced by PCI (Recknagel et al. 2013). A drawback of rodent LPS models is the 
amount of LPS used in the respective experiments. The LD50 dose of LPS in mice was found 
to be about 1000-fold to 10000-fold greater than the dose required to provoke critical septic 
illness in humans (Fink 2014). For that and other reasons, the LPS model has been doubted to 
properly replicate the pathophysiology and pathomechanisms of sepsis (Rittirsch et al. 2007). 
In contrast, PCI appeared to mimic many features characteristic for human sepsis, such as 
coagulation abnormalities, liver dysfunction, microcirculatory defects and concomitant multi-
organ failure (Gonnert et al. 2011). Therefore, LPS models and PCI differ in various 
properties and a comparison of respective observations including cardiac dysfunction are only 
possible to a limited extent. 
 
Another example of model-dependent effects may be the alteration of CPT activity. We did 
not detect any changes in cardiac CPT activity related to sepsis. Both CPT I and II activities 
measured in  septic hearts 24 h after fecal injection were similar to control. In consideration of 
comparable rates of FAO in hearts 24-36 h after sepsis induction and healthy hearts, this result 
appears conclusive. However, it is opposed by previously reported experiments using LPS 
injection instead. In a setup of neonatal sepsis, LPS were injected intraperitoneally to induce 
endotoxemia in suckling rats (Eaton et al. 2003, Fukumoto et al. 2002). CPT I activity was 
observed to be reduced two hours after injection in hearts from endotoxemic animals without 
affection of CPT II. Likewise, intraperitoneal injection of LPS in C57BL/6 mice resulted in a 
significant reduction of CPT I gene expression in the heart (Drosatos et al. 2013). Indeed, the 
down-regulation of CPT I was accompanied by significant impairment of cardiac function and 
additional reduction of FAO, indicating a different cardiac phenotype relative to our model. 
Further studies addressing CPT activities rather focused on hepatic CPT and reported varying 
results. In male Wistar rats, sepsis induced by CLP provoked an increase of CPT activity in 
liver (Yamamoto 1993). In contrast, another study observed decreased CPT activities and 
down-regulation of CPT gene expression in septic Sprague-Dawley rats after CLP (Barke et 
al. 1996). Therefore, CPT activity in context of sepsis remains controversial and appears to be 
dependent on the used model and species. 
Although HCR hearts tended to oxidize more fatty acids than LCR hearts in this study, CPT I 
and II activity seemed not to be influenced by intrinsic exercise capacity. Increased CPT 
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activity could have in part explained the tendential rise in FAO seen in HCR. Previously, a 
1.29-fold up-regulation of CPT I gene expression has been reported for cardiac tissue from 
HCR rats compared to LCR (Bye et al. 2008). Indeed, higher gene expression does not 
automatically result in increases in enzymatic activity due to action of a variety of regulatory 
factors. FAO is not exclusively governed by CPT activity but is controlled by a complex 
network of regulators. The indifferent CPT activities measured in this study imply the 
involvement of further mechanisms in the control of FAO in HCR and LCR hearts. 
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7 Conclusion 
In the current study, the influence of sepsis on cardiac substrate metabolism and function in 
dependence of intrinsic exercise capacity was investigated for the first time. Induction of 
sepsis did not lead to disturbances of basal cardiac metabolism or mechanical dysfunction in 
our animal model. Insulin sensitivity of septic and post-septic hearts appeared preserved. 
Genetic predisposition for intrinsic exercise capacity did not affect substrate preference or 
cardiac performance, neither in acute sepsis nor in sepsis-survivors. 
Therefore, the detrimental outcome of sepsis cannot be attributed to perturbances of cardiac 
substrate metabolism or function. The advantage in survival 24 h after sepsis induction 
previously seen in animals with high intrinsic exercise capacity did not correlate with 
metabolic or functional alterations in the heart; thus, the reasons responsible for this 
advantage remain elusive. 
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